These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 578622)
1. Thyroid vascularity--documentation of the iodide effect in thyrotoxicosis. Brownlie BE; Turner JG; Ellwood MA; Rogers TG; Armstrong DI Acta Endocrinol (Copenh); 1977 Oct; 86(2):317-22. PubMed ID: 578622 [TBL] [Abstract][Full Text] [Related]
2. Effect of Lugol's iodine on the vascularity of thyroid gland in hyperthyroidism. Rangaswamy M; Padhy AK; Gopinath PG; Shukla NK; Gupta K; Kapoor MM Nucl Med Commun; 1989 Sep; 10(9):679-84. PubMed ID: 2616107 [TBL] [Abstract][Full Text] [Related]
3. The influence of preoperative drug treatment on the histological appearances and in vitro 131I uptake of human hyperplastic thyroid gland. Beck JS; Elmslie WH; Harbitz TB; Michie W; Nicol AG; Pegg CA; Young RJ Clin Endocrinol (Oxf); 1975 Sep; 4(5):469-75. PubMed ID: 1175309 [TBL] [Abstract][Full Text] [Related]
4. [Changes of vascular murmurs on the thyroid in hyperthyroid patients during therapeutic treatment]. Strano A; Di Renzi L; Natoli A; Leggio F; Riondino G; Cassone R Boll Soc Ital Cardiol; 1968; 13(6):843-50. PubMed ID: 5745649 [No Abstract] [Full Text] [Related]
5. Control of severe thyrotoxicosis with potassium iodide and propranolol. Nicol EF; Irvine WJ Scott Med J; 1982 Apr; 27(2):172-4. PubMed ID: 7089529 [TBL] [Abstract][Full Text] [Related]
6. Comparison of high and low dosage levels of 131-I in the treatment of thyrotoxicosis. Hagen GA; Ouellette RP; Chapman EM N Engl J Med; 1967 Sep; 277(11):559-62. PubMed ID: 4166909 [No Abstract] [Full Text] [Related]
7. Thyroid morphology and function after subtotal resection for hyperthyroidism. Lundström B; Norrby K Br J Surg; 1980 May; 67(5):357-9. PubMed ID: 7388332 [TBL] [Abstract][Full Text] [Related]
8. Does preoperative iodide treatment for thyrotoxicosis bring about involution? Wilkin TJ; Beck JS; Michie W J Clin Pathol; 1977 Feb; 30(2):99-102. PubMed ID: 845268 [TBL] [Abstract][Full Text] [Related]
9. The sodium-iodide symporter protein is always present at a low expression and confined to the cell membrane in nonfunctioning nonadenomatous nodules of toxic nodular goitre. Tonacchera M; Viacava P; Fanelli G; Agretti P; De Marco G; De Servi M; Di Cosmo C; Chiovato L; Pinchera A; Vitti P Clin Endocrinol (Oxf); 2004 Jul; 61(1):40-5. PubMed ID: 15212643 [TBL] [Abstract][Full Text] [Related]
10. Lymphoid tissue in the thyroid gland and thymus of patients with primary thyrotoxicosis. Beck JS; Young RJ; Simpson JG; Gray ES; Nicol AG; Pegg CA; Michie W Br J Surg; 1973 Oct; 60(10):769-71. PubMed ID: 4748380 [No Abstract] [Full Text] [Related]
11. Thyrotoxicosis in the African: clinical and immunological observations. McGill PE Br Med J; 1971 Jun; 2(5763):679-81. PubMed ID: 5109078 [TBL] [Abstract][Full Text] [Related]
12. Thyroid size and goitre frequency in hyperthyroidism. Hegedüs L; Hansen JE; Veiergang D; Karstrup S Dan Med Bull; 1987 Apr; 34(2):121-3. PubMed ID: 3556045 [TBL] [Abstract][Full Text] [Related]
13. Hyperthyroidism. Maji D J Indian Med Assoc; 2006 Oct; 104(10):563-4, 566-7. PubMed ID: 17380820 [TBL] [Abstract][Full Text] [Related]
14. Is the current use of thyroid scintigraphy rational? Tindall H; Griffiths AP; Penn ND Postgrad Med J; 1987 Oct; 63(744):869-71. PubMed ID: 3447112 [TBL] [Abstract][Full Text] [Related]